Mar 31, 2017 11:05 am UTC| Business
SAN FRANCISCO, March 31, 2017 -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, today announced the approval by the China Food and Drug Administration (CFDA) of the Company’s clinical trial...
Sphere 3D Reports Fourth Quarter and Fiscal Year 2016 Financial Results
Mar 31, 2017 11:02 am UTC| Business
SAN JOSE, Calif., March 31, 2017 -- Sphere 3D Corp. (NASDAQ:ANY), a containerization, virtualization, and data management solutions provider, today reported financial results for its fourth quarter and fiscal year ended...
Mar 31, 2017 11:01 am UTC| Business
GAITHERSBURG, Md., March 31, 2017 -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed a modification to its contract with the Biomedical Advanced Research and Development Authority (BARDA) to...
Mar 31, 2017 11:01 am UTC| Business
GAITHERSBURG, Md., March 31, 2017 -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed a modification to its contract with the Biomedical Advanced Research and Development Authority (BARDA) to...
Mar 31, 2017 11:00 am UTC| Business
BOULDER, Colo., March 31, 2017 -- miRagen Therapeutics, Inc. (Nasdaq:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, today announced that the...
Mar 31, 2017 11:00 am UTC| Business
Charlotte, N.C., March 31, 2017 -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), a manufacturer of patented single-crystal BulkONE® bulk acoustic wave (BAW) high-band RF filters for mobile...
Codexis Signs Second Multi-Year Agreement in Food Industry with Tate & Lyle
Mar 31, 2017 11:00 am UTC| Business
REDWOOD CITY, Calif., March 31, 2017 -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the signing of a multi-year development agreement with Tate Lyle, a global provider of food...